AVRA Medical Robotics, Inc. (OTC: AVMR )
was organized by a senior leadership team with broad and deep experience in medical research, innovation, and development in the medical robotics field. The company plans to exploit the growing demand for practical surgical robotic devices by developing a platform independent precision guidance system with an initial focus on skin resurfacing.
We believe that our Executive Management and Medical and Scientific Advisors have the demonstrated experience and professional skills to develop and market our robotic system successfully.
Our management team has had direct design, engineering and manufacturing experience in complex mechanical operations as well as the administration and supervision of the corporate activities of small and large enterprises ranging from pharma to telecommunications.
Our Medical Advisory Board consists of a number of surgeons who were active in the formative stages of robotic surgery in the United States and who today are numbered the most acknowledged and productive physicians in their specialties.
AVRA believes that its comprehensive and diverse team brings the necessary resources to develop and commercialize intelligent medical robotic systems, as well as in marketing, chain management, and the implementation of all other aspects of business operations.


Market Opportunity:
Aesthetic Medicine
AVRA is currently developing a unique surgical robotic platform in the field of Aesthetics. According to the American Society for Aesthetic Plastic Surgery (ASAPS), the field of aesthetics is a $13.5 billion industry, with explosive growth in non-surgical treatments.
Presented by

AVRA MEDICAL ROBOTICS IN THE NEWS
Patient Inspired Technology
AVRA is a surgical digital technology company whose primary goal is to provide surgeons with the ability to achieve consistently excellent results for the patient. Employing advanced technology, AVRA is developing an intelligent robotic platform combining attributes of imaging with target acquisition and guidance to navigate with unprecedented accuracy and precision. These advanced, semi/autonomous systems will have boundless diagnostic and therapeutic applications — Target, Diagnose, Treat.

Take a virtual tour of the offices of AVRA Medical Robotics via Google Maps below
- AVRA Medical Robotics, Inc. Appoints Dr Onur Toker to Accelerate Development of its Surgical Robotic System
- AVRA Medical Robotics’ Chief Medical Officer to Reveal Company’s Latest Developments in Surgical Robots at Global ConferenceAVRA Medical Robotics’ Chief Medical Officer to Reveal Company’s Latest Developments in Surgical Robots at Global Conference
- AVRA Medical Robotics, Inc. (OTCMKTS: AVMR) 2020 Year-End CEO Update Letter to Shareholders and the Investment Community
-
AVRA Medical Robotics, Inc. (OTC: AVMR) Engages New Auditors
-
AVRA Medical Robotics Attends J.P. Morgan Healthcare Conference
-
AVRA Medical Robotics Initiates Food and Drug Administration Approval Process
-
AVRA Medical Robotics Announces Extension of Research Agreement with University of Central Florida
-
oVio Technologies Partners With AVRA Medical Robotics to Automate Procedures
-
AVRA Medical Robotics Appoints Timothy K. Duggins as Regulatory Consultant.
-
AVRA Medical Robotics Releases Letter to Update Shareholders.
-
Medical robotics company harnesses UCF research for computer-aided surgery.
-
Swedish American Group focuses on cancer, autoimmune diseases at Life Science Summit